|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM366975285 |
| 003 |
DE-627 |
| 005 |
20250305161736.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240114s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202313317
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1222.xml
|
| 035 |
|
|
|a (DE-627)NLM366975285
|
| 035 |
|
|
|a (NLM)38206943
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Li, Xin
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Pillararene-Based Stimuli-Responsive Supramolecular Delivery Systems for Cancer Therapy
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 19.04.2024
|
| 500 |
|
|
|a Date Revised 19.04.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2024 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a Cancer poses a significant challenge to global public health, seriously threatening human health and life. Although various therapeutic strategies, such as chemotherapy (CT), radiotherapy, phototherapy, and starvation therapy, are applied to cancer treatment, their limited therapeutic effect, severe side effects, and unsatisfactory drug release behavior need to be carefully considered. Thus, there is an urgent need to develop efficient drug delivery strategies for improving cancer treatment efficacy and realizing on-demand drug delivery. Notably, pillararenes, as an emerging class of supramolecular macrocycles, possess unique properties of highly tunable structures, superior host-guest chemistry, facile modification, and good biocompatibility, which are widely used in cancer therapy to achieve controllable drug release and reduce the toxic side effects on normal tissues under various internal/external stimuli conditions. This review summarizes the recent advance of stimuli-responsive supramolecular delivery systems (SDSs) based on pillararenes for tumor therapy from the perspectives of different assembly methods and hybrid materials, including molecular-scale SDSs, supramolecular nano self-assembly delivery systems, and nanohybrid SDSs. Moreover, the prospects and critical challenges of stimuli-responsive SDSs based on pillararenes for cancer therapy are also discussed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a biomaterials
|
| 650 |
|
4 |
|a cancer therapy
|
| 650 |
|
4 |
|a drug delivery
|
| 650 |
|
4 |
|a hybrid materials
|
| 650 |
|
4 |
|a supramolecular chemistry
|
| 700 |
1 |
|
|a Shen, Meili
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yang, Jie
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Linlin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yang, Ying-Wei
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 16 vom: 01. Apr., Seite e2313317
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:16
|g day:01
|g month:04
|g pages:e2313317
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202313317
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 16
|b 01
|c 04
|h e2313317
|